ILMN · Illumina, Inc. · Executive Compensation
$192.82
-7.84 (-3.90%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$29.15B
Shares
151.20M
Volume · Nov 20
1.96M
Avg daily vol (3M)
2.81M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jacob Thaysen | Chief Executive Officer | $11,018,895 |
| Everett Cunningham | Former Chief Commercial Officer | $4,087,101 |
| Ankur Dhingra | Chief Financial Officer | $4,078,071 |
| Steve Barnard | Chief Technology Officer | $3,480,152 |
| Kevin Pegels | Chief of Global Operations | $3,180,020 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jacob Thaysen | Chief Executive Officer | $14,802,924 |
| Everett Cunningham | Chief Commercial Officer | $10,073,818 |
| Ankur Dhingra | Chief Financial Officer | $5,856,087 |
| Charles Dadswell | Former General Counsel & Secretary | $4,517,203 |
| Joydeep Goswami | Former Chief Financial Officer, Chief Strategy and Corporate Development Officer | $4,243,761 |
| Steve Barnard | Chief Technology Officer | $4,020,936 |
| Kevin Pegels | Chief of Global Operations | $3,849,842 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Francis deSouza | Former Chief Executive Officer | $14,494,506 |
| Susan Tousi | Former Chief Commercial Officer | $5,334,653 |
| Joydeep Goswami | Former Chief Financial Officer, Chief Strategy and Corporate Development Officer | $5,314,177 |
| Alex Aravanis | Former Chief Technology Officer, Head of Research and Product Development | $5,069,310 |
| Jacob Thaysen | Chief Executive Officer | $4,691,233 |
| Phil Febbo | Former Chief Medical Officer | $4,526,469 |
| Charles Dadswell | Former General Counsel & Secretary | $4,139,866 |
| Kathryne Reeves | Former Chief Marketing Officer | $3,798,535 |
| Carissa Rollins | Chief Information Officer | $2,928,969 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Francis deSouza | Former Chief Executive Officer | $26,752,197 |
| Susan Tousi | Former Chief Commercial Officer | $8,790,558 |
| Alex Aravanis | Former Chief Technology Officer, Head of Research and Product Development | $8,747,014 |
| Phil Febbo | Former Chief Medical Officer | $4,722,318 |
| Joydeep Goswami | Former Chief Financial Officer, Chief Strategy and Corporate Development Officer | $3,537,626 |
| Charles Dadswell | Former General Counsel & Secretary | $3,477,849 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Robert Ragusa | Former Chief Operations Officer | $22,885,222 |
| Francis deSouza | Former Chief Executive Officer | $14,333,634 |
| Alex Aravanis | Former Chief Technology Officer, Head of Research and Product Development | $5,051,507 |
| Susan Tousi | Former Chief Commercial Officer | $5,041,489 |
| Charles Dadswell | General Counsel & Secretary | $3,561,286 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Francis A. deSouza | Chief Executive Officer; Director | $11,733,593 |
| Alex Aravanis | Chief Technology Officer, Head of Research and Product Development | $5,416,844 |
| Mark Van Oene | Former Chief Commercial Officer | $3,245,633 |
| Susan Tousi | Chief Commercial Officer | $3,155,422 |
| Sam Samad | Chief Financial Officer | $2,466,176 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Joydeep Goswami | Senior Vice President, Corporate Development and Strategic Planning | $1,984,825 |
| Francis A. deSouza | Chief Executive Officer; Director | $1,521,949 |
| Aimee Hoyt | Senior Vice President & Chief People Officer | $864,073 |
| Omead Ostadan | Chief Product and Marketing Officer | $744,101 |
| Sam Samad | Chief Financial Officer | $626,703 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Francis A. deSouza | Chief Executive Officer; Director | $11,067,566 |
| Omead Ostadan | Chief Product and Marketing Officer | $4,716,935 |
| Aimee Hoyt | Senior Vice President & Chief People Officer | $3,857,171 |
| Sam A. Samad | Chief Financial Officer | $2,897,197 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Francis A. deSouza | President and CEO; Director | $8,807,716 |
| Omead Ostadan | Chief Product and Marketing Officer | $3,453,544 |
| Sam A. Samad | Senior Vice President and Chief Financial Officer | $3,290,350 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel M. Skovronsky, M.D., Ph.D. | Board of Directors | Appointed | 2026-06-23 |
|
Gary S. Guthart
“The retirements of Drs. Arnold, Epstein and Guthart are not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
|
director | Retired | 2026-04-02 |
|
Robert S. Epstein
“The retirements of Drs. Arnold, Epstein and Guthart are not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
|
director | Retired | 2026-04-02 |
|
Frances Arnold
“The retirements of Drs. Arnold, Epstein and Guthart are not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
|
director | Retired | 2026-04-02 |
| Eric D. Green, M.D., Ph.D. | Chief Medical Officer (CMO) | Appointed | 2026-01-08 |
| Everett Cunningham | Chief Commercial Officer | Resigned | 2026-01-08 |
| Scott Gottlieb | non-executive Chair | Appointed | 2025-03-25 |
| Keith A. Meister | director | Appointed | 2025-03-25 |
|
Stephen P. MacMillan
“Mr. MacMillan’s resignation is not the result of any dispute or disagreement with the Company or the Company’s Board of Directors on any matter relating to the operations, policies or practices of the Company.”
|
director | Resigned | 2025-03-25 |
| Carissa Rollins | Chief Information Officer | Retired | 2025-03-24 |
| Scott Davies | Interim General Counsel and Secretary | Appointed | 2024-10-03 |
| Charles Dadswell | General Counsel and Secretary | Resigned | 2024-10-03 |
|
Joydeep Goswami
“This departure is not the result of any disagreement on matters relating to the Company's operations or its financial reporting, policies, or practices.”
|
Chief Strategy and Development Officer | Resigned | 2024-04-09 |
| Jakob Wedel | Chief Strategy and Corporate Development Officer | Appointed | 2024-04-09 |
| Ankur Dhingra | Chief Financial Officer | Appointed | 2024-04-09 |
| Bas Verhoef | Interim Chief Commercial Officer | Appointed | 2024-01-04 |
| Susan Tousi | Chief Commercial Officer | Resigned | 2024-01-04 |
| Jacob Thaysen | member of the Board | Appointed | 2023-09-05 |
| Jacob Thaysen | Chief Executive Officer | Appointed | 2023-09-05 |
| Steven Barnard | Chief Technology Officer | Appointed | 2023-08-09 |
| Alex Aravanis | Chief Technology Officer | Resigned | 2023-08-09 |
| Phil Febbo | Chief Medical Officer | Resigned | 2023-08-09 |
| Charles Dadswell | interim Chief Executive Officer | Appointed | 2023-06-13 |
| Francis deSouza | director | Resigned | 2023-06-13 |
| Francis deSouza | Chief Executive Officer | Resigned | 2023-06-13 |
Leadership
- Jay T. Flatley Chairman
- John W. Thompson Chairman
- Scott Gottlieb Chairman, Board Member
- Stephen P. MacMillan Chairman, Board Member
- Ankur Dhingra CFO
- Steve Barnard CTO
- Steven Barnard CTO
- Charles Dadswell General Counsel
- Scott Davies General Counsel
- Jose Torres Chief Accounting Officer
- Scott Ericksen Chief Accounting Officer
- Andrew J. Teno Board Member
- Anna Richo Board Member
- Caroline D. Dorsa Board Member
- Caroline Dorsa Board Member
- Daniel M. Skovronsky, M.D., Ph.D. Board Member
- David King Board Member
- David P. King Board Member
- Frances Arnold Board Member
- Frances Arnold, Ph.D. Board Member
- Francis A. deSouza Board Member
- Gary S. Guthart, Ph.D. Board Member
- Jacob Thaysen Board Member
- Keith A. Meister Board Member
- Keith Meister Board Member
- Philip Schiller Board Member
- Philip W. Schiller Board Member
- Robert S. Epstein, M.D. Board Member
- Scott B. Ullem Board Member
- Scott Gottlieb, M.D. Board Member
- Scott Ullem Board Member
- Susan E. Siegel Board Member
- Susan Siegel Board Member
Key facts
CIK
1110803
CUSIP
452327109
13F (30d)
1013 filings
924 filers
Visit website
Investor relations